Moderna stock surged Wednesday after Oracle Chairman Larry Ellison praised the potential of AI in developing medicines.
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Investor's Business Daily on MSN5h
Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?Moderna's technology focuses on helping the body create specific messenger RNA, or mRNA. When the mRNA sees ... Moderna sells ...
US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...
The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...
In this review of RNA therapies, we paint an overview of what’s going on in a field that is addressing a number of diseases.
SINGAPORE - People who are eligible for the Novavax Covid-19 vaccine can go to selected clinics from Jan 24 to April 30 for ...
Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite the development of mRNA-based pandemic influenza vaccines. The initiative is part ...
Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.
We rate BioNTech SE a hold due to volatile performance, weak growth, and premium valuation amidst COVID-19 vaccine reliance.
The U.S. Department of Health and Human Services or HHS said it will provide approximately $590 million to Moderna (MRNA) to ...
Biopharma executives were busy Monday, striking high-value deals and providing updates on cancer, obesity and vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback